NYSE:HHS Harte Hanks (HHS) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free HHS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$6.97▼$7.1650-Day Range$2.69▼$2.9452-Week Range$1.10▼$3.96Volume40,088 shsAverage Volume14,631 shsMarket Capitalization$51.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisCompetitorsEarningsHeadlinesInsider TradesOwnershipSocial Media Get Harte Hanks alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Harte Hanks Stock (NYSE:HHS)Harte-Hanks, Inc. engages in the provision of marketing solutions. It specializes in consulting, data analytics, creative services, digital and social media, marketing strategy, marketing technology, and other related services. It supports a range of customers in the field of technology, travel and leisure, entertainment, pharmaceuticals, automotive, finance, and retail. The company was founded in 1923 and is headquartered in San Antonio, TX.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> HHS Stock News HeadlinesApril 4, 2024 | finance.yahoo.comHarte Hanks Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 18, 2024 | finance.yahoo.comIs There An Opportunity With Harte Hanks, Inc.'s (NASDAQ:HHS) 31% Undervaluation?April 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 16, 2024 | seekingalpha.comHarte Hanks, Inc. (HHS) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comQ4 2023 Harte Hanks Inc Earnings CallMarch 14, 2024 | msn.comHHS Stock Earnings: Harte-Hanks Beats EPS, Beats Revenue for Q4 2023March 14, 2024 | finanznachrichten.deHarte Hanks, Inc.: Harte Hanks Reports Fourth Quarter and Fiscal 2023 Full-Year ResultsMarch 7, 2024 | investorplace.com3 Hidden-Gem Stocks Poised for a 10X Surge This DecadeApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 4, 2024 | investorplace.comBargain Buys: 3 Stocks Under $20 with Triple-Digit Growth PotentialFebruary 19, 2024 | finance.yahoo.com3 Small-Cap Stocks With Mega-Cap Potential for 10X GainsFebruary 16, 2024 | investorplace.com3 Small-Cap Stars With the Power to Triple Your Investment by 2026February 5, 2024 | finanznachrichten.deHarte Hanks, Inc.: Varsha Tomar and Luke Kenny Join Harte Hanks in Senior Sales RolesFebruary 5, 2024 | finance.yahoo.comVarsha Tomar and Luke Kenny Join Harte Hanks in Senior Sales RolesJanuary 29, 2024 | finance.yahoo.comHarte Hanks Strengthens Senior Leadership TeamJanuary 23, 2024 | finance.yahoo.comHere's Why Harte Hanks (NASDAQ:HHS) Has Caught The Eye Of InvestorsJanuary 4, 2024 | finanznachrichten.deHarte Hanks, Inc.: Harte Hanks Extends Line of Credit with Texas Capital BankJanuary 4, 2024 | finance.yahoo.comHarte Hanks Extends Line of Credit with Texas Capital BankJanuary 3, 2024 | finance.yahoo.comGreater Boston-Based Harte Hanks Continues Growth Phase with Addition of Global Advertising Executive Elizabeth Ross to Board of DirectorsDecember 6, 2023 | benzinga.com144K Reasons To Be Bullish On Harte-Hanks StockDecember 5, 2023 | finance.yahoo.comDirector Bradley Radoff's Strategic 20,000 Share Acquisition of Harte-Hanks IncDecember 2, 2023 | finance.yahoo.comBradley Radoff Bought 9.4% More Shares In Harte HanksNovember 27, 2023 | finance.yahoo.comInvestors Will Want Harte Hanks' (NASDAQ:HHS) Growth In ROCE To PersistNovember 12, 2023 | morningstar.comHarte-Hanks Inc HHSNovember 10, 2023 | finance.yahoo.comHarte Hanks, Inc. (NASDAQ:HHS) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | finance.yahoo.comHarte Hanks Reports Fiscal 2023 Third Quarter ResultsNovember 8, 2023 | finance.yahoo.comZacks Industry Outlook Highlights Omnicom Group, National CineMedia and Harte HanksSee More Headlines Receive HHS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Harte Hanks and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today4/26/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Direct mail advertising services Sub-IndustryAdvertising Current SymbolNYSE:HHS CUSIP41619610 CIK45919 Webwww.hartehanks.com Phone(512) 434-1100Fax210-829-9139Employees1,962Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.22) Trailing P/E RatioN/A Forward P/E Ratio13.96 P/E Growth1.15Net Income$-1,570,000.00 Net Margins-0.82% Pretax Margin-1.00% Return on Equity14.27% Return on Assets2.52% Debt Debt-to-Equity RatioN/A Current Ratio1.36 Quick Ratio1.36 Sales & Book Value Annual Sales$191.49 million Price / Sales0.26 Cash Flow$0.99 per share Price / Cash Flow7.04 Book Value$2.75 per share Price / Book2.54Miscellaneous Outstanding Shares7,240,000Free Float6,352,000Market Cap$50.54 million OptionableNot Optionable Beta0.64 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesAndrew B. BenettExecutive Chairman & Chief Executive OfficerBrian LinscottChief Operating OfficerLaurilee KearnesChief Financial Officer & Vice PresidentMichael J. HastingsSenior Vice President-Marketing TechnologyKeith SedlakChief Growth OfficerKey CompetitorsPono CapitalNASDAQ:PONOCXAppNASDAQ:CXAIuCloudlink GroupNASDAQ:UCLHudson GlobalNASDAQ:HSONSkillsoftNASDAQ:SKILView All CompetitorsInsiders & InstitutionsKrilogy Financial LLCSold 4,000 shares on 4/24/2024Ownership: 1.209%Bradley Louis RadoffBought 20,000 shares on 12/1/2023Total: $144,600.00 ($7.23/share)Bradley Louis RadoffBought 10,000 shares on 11/29/2023Total: $68,200.00 ($6.82/share)Kirk A DavisBought 5,739 shares on 11/15/2023Total: $40,574.73 ($7.07/share)John H Griffin JrBought 771 shares on 8/17/2023Total: $4,356.15 ($5.65/share)View All Insider TransactionsView All Institutional Transactions HHS Stock Analysis - Frequently Asked Questions When is Harte Hanks' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our HHS earnings forecast. How can I listen to Harte Hanks' earnings call? Harte Hanks will be holding an earnings conference call on Thursday, May 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 919-882-2331 with passcode "50446". How were Harte Hanks' earnings last quarter? Harte Hanks, Inc. (NYSE:HHS) posted its quarterly earnings results on Thursday, March, 14th. The business services provider reported $0.35 earnings per share for the quarter. The business services provider earned $49.49 million during the quarter, compared to the consensus estimate of $47 million. Harte Hanks had a negative net margin of 0.82% and a positive trailing twelve-month return on equity of 14.27%. What other stocks do shareholders of Harte Hanks own? Based on aggregate information from My MarketBeat watchlists, some companies that other Harte Hanks investors own include Amyris (AMRS), Eldorado Resorts (ERI), Nokia Oyj (NOK), NVIDIA (NVDA), Block (SQ), Inovio Pharmaceuticals (INO), Prospect Capital (PSEC), Ambarella (AMBA), Delta Air Lines (DAL) and Telefonaktiebolaget LM Ericsson (publ) (ERIC). Who are Harte Hanks' major shareholders? Harte Hanks' stock is owned by a number of institutional and retail investors. Top institutional investors include Krilogy Financial LLC (1.21%). Insiders that own company stock include Bradley Louis Radoff, Brian Linscott, David L Copeland, John H Griffin Jr, Kirk A Davis, Laurilee Kearnes and Robert T Wyman. View institutional ownership trends. This page (NYSE:HHS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harte Hanks, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
